The p38 MAPK activity inhibition with specific inhibitor VX‐745 led to cell‐type‐specific periodical changes in the molecular clock, indicating potential therapeutic use of VX‐745 in glioma chronotherapy.104. The gene discussed is CLOCK; the disease is central nervous system cancer.